Prometheus Biosciences Story
| RXDXDelisted Stock | USD 199.92 0.24 0.12% |
Slightly above 55% of Prometheus Biosciences' investor base is interested to short. The analysis of current outlook of investing in Prometheus Biosciences suggests that many traders are impartial regarding Prometheus Biosciences' prospects. Prometheus Biosciences' investor sentiment overview provides quick insight into current market opportunities from investing in Prometheus Biosciences. The current market sentiment, together with Prometheus Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Prometheus Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Prometheus Biosciences stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Prometheus daily returns and investor perception about the current price of Prometheus Biosciences as well as its diversification or hedging effects on your existing portfolios.
Prometheus |
Requested story not found. it has been either deleted or moved. View all stories for Prometheus Biosciences.
Prometheus Biosciences Latest Timeline
Prometheus Biosciences is listed for 199.92. About 17.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 3.54. Prometheus Biosciences had not issued any dividends in recent years. The entity had 1:100 split on the 1st of November 2013.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the Prometheus Biosciences information on this page should be used as a complementary analysis to other Prometheus Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Prometheus Stock
If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |